The fund is generally included in 2-6 deals every year. The top activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Among the most successful fund investment fields, there are Health Care, Artificial Intelligence. Among the various public portfolio startups of the fund, we may underline Huimei Technology Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 4-5 partakers. The meaningful sponsors for the fund in investment in the same round are WuXi AppTec, Sherpa Venture Capital, Qiming Venture Partners.
Related Funds
| Fund Name | Location |
| Angeles Investors | - |
| Datiotec Electronics | - |
| Highbridge Capital Management | New York, New York, United States |
| Hudson Bay Capital Management | New York, New York, United States |
| iSGS Investment Works | Chiyoda, Japan |
| Ledstiernan | Stockholm, Stockholm County, Sweden |
| National Cancer Research Institute | England, London, United Kingdom |
| TASC | Chantilly, United States, Virginia |
| The Hillman Group | Cincinnati, Ohio, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Chengdu Pukang Biotechnology Co. | 06 Jun 2024 | Chengdu, Sichuan, China | |||
Xushui Internet | 19 Mar 2024 | Beijing, Beijing, China | |||
Sensview | 18 Jul 2023 | Chengdu, Sichuan, China | |||
Zilixir Biotech | $15M | 25 May 2023 | Shanghai, Shanghai, China | ||
Bio-Engine | $46M | 15 May 2023 | Shanghai, China | ||
Xinrui Medical | 09 Mar 2023 | Suzhou, Jiangsu, China | |||
LePure Biotech | 12 Jan 2023 | Shanghai, Shanghai, China | |||
Jinjiang Electronics | $108M | 22 Aug 2022 | Chengdu, Sichuan, China | ||
Proton Bio | $80M | 19 Aug 2022 | Suzhou, Jiangsu, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Chengdu Pukang Biotechnology Co. | 06 Jun 2024 | Chengdu, Sichuan, China | |||
Xushui Internet | 19 Mar 2024 | Beijing, Beijing, China | |||
Sensview | 18 Jul 2023 | Chengdu, Sichuan, China | |||
Zilixir Biotech | $15M | 25 May 2023 | Shanghai, Shanghai, China | ||
Bio-Engine | $46M | 15 May 2023 | Shanghai, China | ||
Xinrui Medical | 09 Mar 2023 | Suzhou, Jiangsu, China | |||
LePure Biotech | 12 Jan 2023 | Shanghai, Shanghai, China | |||
Jinjiang Electronics | $108M | 22 Aug 2022 | Chengdu, Sichuan, China | ||
Proton Bio | $80M | 19 Aug 2022 | Suzhou, Jiangsu, China |
